A study investigated the safety of nephrectomy after exposure to HIF-2α antagonists for localized VHL-deficient kidney cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback